Rajiv Vinnakota
Known title: DirectorCIK: 0001431876
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Enovis Gathers Fresh Attention After Reaffirming 2026 Guidance. Enovis has attracted new interest as analysts discuss its 2026 outlook. A recent review lowered the price target to $34 while maintaining a positive stance. The stock is trading near the top of its 52‑week range, and recent signals show a breakout and positive RSI divergence. These developments may influence how investors view the company’s valuation.
Transaction History
| ESAB | ▲ Buy | Option Exercise | 637 | — | 6/1/2026 | View on chart |
| ENOV | ▲ Buy | Grant | 9,346 | $0 | 5/19/2026 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 2,783 | $92K | 11/11/2025 | View on chart |
| ESAB | ▼ Sell | Open Market | 2,783 | $319K | 11/11/2025 | View on chart |
| ESAB | ▼ Sell | Other | 7 | $874 | 7/18/2025 | View on chart |
| ENOV | ▲ Buy | Grant | 6,598 | $0 | 5/21/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 703 | $0 | 5/9/2025 | View on chart |
| ESAB | ▼ Sell | Other | 6 | $642 | 4/17/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 2,127 | $86K | 2/28/2025 | View on chart |
| ESAB | ▼ Sell | Open Market | 2,127 | $262K | 2/28/2025 | View on chart |
| ESAB | ▼ Sell | Other | 5 | $642 | 1/16/2025 | View on chart |
| ENOV | ▲ Buy | Grant | 4,338 | $0 | 5/20/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 1,236 | $0 | 5/11/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 1,700 | $84K | 3/6/2024 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 844 | $84K | 3/6/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 856 | $85K | 3/6/2024 | View on chart |
| ENOV | ▲ Buy | Grant | 1,875 | $0 | 5/16/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 1,468 | $0 | 5/12/2023 | View on chart |
| ENOV | ▲ Buy | Option Exercise | 1,396 | $59K | 5/8/2023 | View on chart |
| ENOV | ▼ Sell | Open Market | 1,396 | $80K | 5/8/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 1,905 | $59K | 3/10/2023 | View on chart |
| ESAB | ▼ Sell | Open Market | 1,905 | $116K | 3/10/2023 | View on chart |
| ENOV | ▲ Buy | Grant | 1,648 | $0 | 6/7/2022 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 1,321 | $0 | 5/12/2022 | View on chart |
| ENOV | ▼ Sell | Other | 968 | $0 | 4/5/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 2,213 | $103K | 9/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
ESAB Schedules Q3 2026 Earnings Call Amid Mixed Stock Performance
ESAB has announced the schedule for its third-quarter 2026 earnings release and conference call. This announcement follows a period of mixed price action, with recent reports noting both sharp declines and significant gains in the stock. The company is preparing to share updated financial results as investors monitor its performance against a 52-week range of $64.83 to $137.42.
ESAB Schedules Q3 2026 Earnings Call Amid Mixed Stock Performance. ESAB has announced the schedule for its third-quarter 2026 earnings release and conference call. This announcement follows a period of mixed price action, with recent reports noting both sharp declines and significant gains in the stock. The company is preparing to share updated financial results as investors monitor its performance against a 52-week range of $64.83 to $137.42.